Literature DB >> 28551789

Mitochondria and Cardiac Hypertrophy.

Heberty di Tarso Fernandes Facundo1, Robert Eli Brainard2, Francisco Rodrigo de Lemos Caldas3, Aline Maria Brito Lucas4.   

Abstract

Cardiac tissue responds to long-term hemodynamic load through initiation of a hypertrophic remodeling program. Importantly, if not counteracted this response will eventually lead to organ failure. Cardiac hypertrophic adaptations are complex, and involve multiple cellular events and the mechanisms underlying the development of cardiac hypertrophy are not well understood. Mitochondrial dysfunction has been indicated as a potential and important player in the development of cardiac hypertrophy. Additionally, substantial evidence shows that a significant portion of mitochondrial processes, necessary for normal cardiomyocyte physiology, are impacted by these hypertrophic changes. In this chapter, we will present and discuss the adaptations and changes in the mitochondrial electron transport system, mitochondrial metabolism, mitochondrial biogenesis, oxidative stress, the opening of the mitochondrial permeability transition pore following hypertrophic stimuli, as well as, review the various drugs (targeting mitochondria) that can be used in treatment of cardiac hypertrophy.

Entities:  

Keywords:  Antioxidants; Eletron Transport Chain; Hypertrophy; Mitochondria; Oxidation; Oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28551789     DOI: 10.1007/978-3-319-55330-6_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

1.  Rats with a Human Mutation of NFU1 Develop Pulmonary Hypertension.

Authors:  Maki Niihori; Cody A Eccles; Sergey Kurdyukov; Marina Zemskova; Mathews Valuparampil Varghese; Anna A Stepanova; Alexander Galkin; Ruslan Rafikov; Olga Rafikova
Journal:  Am J Respir Cell Mol Biol       Date:  2020-02       Impact factor: 6.914

Review 2.  Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy.

Authors:  David Aluja; Sara Delgado-Tomás; Marisol Ruiz-Meana; José A Barrabés; Javier Inserte
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

3.  Sustained Oligomycin Sensitivity Conferring Protein Expression in Cardiomyocytes Protects Against Cardiac hypertrophy Induced by Pressure Overload via Improving Mitochondrial Function.

Authors:  Yingying Guo; Kailiang Zhang; Xu Gao; Zhou Zhou; Zhiheng Liu; Kevin Yang; Kai Huang; Qinglin Yang; Qinqiang Long
Journal:  Hum Gene Ther       Date:  2020-09-21       Impact factor: 5.695

4.  Melatonin Efficacy in Obese Leptin-Deficient Mice Heart.

Authors:  Alessandra Stacchiotti; Gaia Favero; Lorena Giugno; Igor Golic; Aleksandra Korac; Rita Rezzani
Journal:  Nutrients       Date:  2017-12-05       Impact factor: 5.717

5.  Pyrroloquinoline quinone attenuates isoproterenol hydrochloride‑induced cardiac hypertrophy in AC16 cells by inhibiting the NF‑κB signaling pathway.

Authors:  Junru Wen; Junwei Shen; Yajie Zhou; Xianhui Zhao; Zhensheng Dai; Yueling Jin
Journal:  Int J Mol Med       Date:  2020-01-10       Impact factor: 4.101

6.  Ndufs1 Deficiency Aggravates the Mitochondrial Membrane Potential Dysfunction in Pressure Overload-Induced Myocardial Hypertrophy.

Authors:  Rongjun Zou; Jun Tao; Junxiong Qiu; Wanting Shi; Minghui Zou; Weidan Chen; Wenlei Li; Na Zhou; Shaoli Wang; Li Ma; Xinxin Chen
Journal:  Oxid Med Cell Longev       Date:  2021-03-03       Impact factor: 6.543

7.  Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes.

Authors:  Bing-Yan Liu; Ling Li; Gao-Li Liu; Wei Ding; Wen-Guang Chang; Tao Xu; Xiao-Yu Ji; Xian-Xin Zheng; Jing Zhang; Jian-Xun Wang
Journal:  Acta Pharmacol Sin       Date:  2020-08-14       Impact factor: 6.150

8.  Application of Zebrafish Model in the Suppression of Drug-Induced Cardiac Hypertrophy by Traditional Indian Medicine Yogendra Ras.

Authors:  Acharya Balkrishna; Yashika Rustagi; Kunal Bhattacharya; Anurag Varshney
Journal:  Biomolecules       Date:  2020-04-13

Review 9.  Three-dimensional electron microscopy techniques for unravelling mitochondrial dysfunction in heart failure and identification of new pharmacological targets.

Authors:  Hussam M Daghistani; Bodour S Rajab; Ashraf Kitmitto
Journal:  Br J Pharmacol       Date:  2018-10-25       Impact factor: 8.739

Review 10.  Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy.

Authors:  Dan Yang; Han-Qing Liu; Fang-Yuan Liu; Zhen Guo; Peng An; Ming-Yu Wang; Zheng Yang; Di Fan; Qi-Zhu Tang
Journal:  Front Cardiovasc Med       Date:  2022-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.